Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Minerva Neurosciences, Inc

NERV Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of NERV by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
NERV Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
NERV Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
NERV Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in NERV holdings by institutional investors

Quarterly net insider trading by NERV's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for NERV

Quiver Logo

No former government officials on record as having lobbied for NERV

Revolving Door Dashboard

NERV Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

NERV Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
NERV Income Statement
NERV Balance Sheet
NERV Cash Flow
U.S. Patents

New NERV patent grants

  • Patent Title: Gastro-resistant controlled release oral dosage forms Jul. 30, 2024
  • Patent Title: Sigma ligand compounds and uses thereof Jun. 11, 2024
  • Patent Title: Methods of using a phenoxypropylamine compound to treat pain Sep. 26, 2023
  • Patent Title: Gastro-resistant controlled release oral dosage forms Oct. 11, 2022
  • Patent Title: Use of roluperidone to treat negative symptoms and disorders, increase neuroplasticity, and promote neuroprotection Aug. 10, 2021
  • Patent Title: Compositions and methods for treating schizophrenia Oct. 13, 2020
  • Patent Title: Compositions and methods for treating schizophrenia Apr. 16, 2019
  • Patent Title: Methods of use of cyclic amide derivatives to treat schizophrenia Aug. 15, 2017
  • Patent Title: Compositions and methods for treating schizophrenia Aug. 15, 2017
  • Patent Title: Compositions and methods for treating schizophrenia Oct. 04, 2016
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to NERV from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
NERV News

Recent insights relating to NERV

CNBC Recommendations

Recent picks made for NERV stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NERV

NERV Analyst Ratings

NERV Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
NERV Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $NERV stock a Buy, Sell, or Hold?

  • What is the price target for $NERV stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

NERV Top Shareholders
Shareholder
Shares Held
NERV Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $NERV stock?

  • Who owns the most shares of $NERV stock?

  • What funds own $NERV stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

NERV Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view NERV Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About NERV

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

  • Address Burlington, MA
  • Market Cap 166.6 million
  • Employees 7
  • Industrial Classification Pharmaceutical Preparations

Minerva Neurosciences, Inc (NERV) Historical Stock Prices

Minerva Neurosciences, Inc (NERV) closed at $3.49 on September 23, 2026. Over the past year its adjusted close ranged from $2.09 to $8.07. Daily prices go back to July 1, 2014, 3,075 trading days in all.

  • 1 month-27.44%
  • 3 months-19.40%
  • Year to date-13.18%
  • 1 year+67.25%
  • 3 years-54.68%
  • 5 years-78.62%
  • Max-92.79%
See every congressional and insider trade on the NERV price chart

Quiver Premium charts NERV's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 3.78 3.78 3.45 3.49 3.49 130,457
Sep 22, 2026 3.71 3.86 3.66 3.81 3.81 123,932
Sep 21, 2026 3.72 3.81 3.59 3.69 3.69 148,622
Sep 18, 2026 3.46 3.80 3.43 3.66 3.66 815,431
Sep 17, 2026 3.56 3.63 3.44 3.46 3.46 229,106
Sep 16, 2026 3.83 3.88 3.48 3.48 3.48 224,509
Sep 15, 2026 4.01 4.05 3.57 3.83 3.83 287,173
Sep 14, 2026 4.30 4.38 3.98 4.01 4.01 119,437
Sep 11, 2026 4.24 4.38 4.13 4.15 4.15 135,947
Sep 10, 2026 4.10 4.24 4.10 4.16 4.16 72,103
Sep 9, 2026 4.35 4.43 4.10 4.12 4.12 112,061
Sep 8, 2026 4.40 4.46 4.32 4.37 4.37 91,832
Sep 4, 2026 4.66 4.80 4.42 4.43 4.43 78,437
Sep 3, 2026 4.53 4.72 4.39 4.69 4.69 151,224
Sep 2, 2026 4.50 4.60 4.46 4.48 4.48 82,825
Sep 1, 2026 4.53 4.64 4.46 4.48 4.48 90,773
Aug 31, 2026 4.82 4.88 4.52 4.56 4.56 116,334
Aug 28, 2026 5.17 5.30 4.82 4.84 4.84 136,733
Aug 27, 2026 5.43 5.43 5.03 5.13 5.13 90,000
Aug 26, 2026 5.01 5.63 4.98 5.43 5.43 383,961
Aug 25, 2026 4.85 5.20 4.71 5.00 5.00 114,406
Aug 24, 2026 4.79 4.94 4.63 4.81 4.81 111,846
Aug 21, 2026 4.79 5.07 4.79 4.84 4.84 106,450
Aug 20, 2026 4.76 4.88 4.64 4.79 4.79 133,135
Aug 19, 2026 4.62 4.96 4.60 4.79 4.79 2,278,050
Aug 18, 2026 4.42 4.56 4.34 4.54 4.54 100,757
Aug 17, 2026 4.54 4.58 4.40 4.42 4.42 110,019
Aug 14, 2026 4.42 4.79 4.30 4.58 4.58 340,693
Aug 13, 2026 3.96 4.09 3.84 3.92 3.92 137,421
Aug 12, 2026 4.31 4.56 3.90 3.92 3.92 138,335
Aug 11, 2026 4.62 4.67 4.29 4.32 4.32 82,231
Aug 10, 2026 4.23 4.66 4.23 4.62 4.62 92,765
Aug 7, 2026 4.39 4.56 4.14 4.27 4.27 171,167
Aug 6, 2026 4.39 4.58 4.21 4.44 4.44 269,887
Aug 5, 2026 4.06 4.37 3.97 4.35 4.35 116,418
Aug 4, 2026 4.00 4.15 4.00 4.04 4.04 84,926
Aug 3, 2026 3.95 4.13 3.95 3.97 3.97 83,772
Jul 31, 2026 4.02 4.06 3.85 3.98 3.98 70,699
Jul 30, 2026 4.12 4.22 3.97 4.02 4.02 91,796
Jul 29, 2026 4.28 4.30 3.95 4.09 4.09 163,498
Jul 28, 2026 4.19 4.38 3.95 4.28 4.28 199,222
Jul 27, 2026 4.09 4.28 3.95 4.21 4.21 168,092
Jul 24, 2026 4.48 4.48 4.00 4.04 4.04 172,721
Jul 23, 2026 4.34 4.68 4.27 4.45 4.45 135,632
Jul 22, 2026 4.47 4.55 4.16 4.43 4.43 159,277
Jul 21, 2026 4.36 4.54 4.15 4.48 4.48 228,503
Jul 20, 2026 4.27 4.46 4.09 4.37 4.37 183,136
Jul 17, 2026 4.13 4.41 4.01 4.27 4.27 169,908
Jul 16, 2026 4.28 4.50 4.09 4.21 4.21 166,345
Jul 15, 2026 4.03 4.35 3.94 4.32 4.32 186,919
Jul 14, 2026 4.29 4.34 4.01 4.02 4.02 170,812
Jul 13, 2026 4.68 4.68 4.27 4.27 4.27 160,824
Jul 10, 2026 4.70 4.85 4.25 4.72 4.72 235,006
Jul 9, 2026 4.63 4.77 4.53 4.72 4.72 195,426
Jul 8, 2026 4.69 4.72 4.55 4.62 4.62 166,225
Jul 7, 2026 4.92 4.95 4.59 4.77 4.77 188,422
Jul 6, 2026 5.07 5.10 4.72 4.92 4.92 239,551
Jul 2, 2026 5.18 5.36 4.73 5.10 5.10 286,901
Jul 1, 2026 5.55 5.55 5.13 5.15 5.15 124,225
Jun 30, 2026 5.47 5.84 5.41 5.55 5.55 221,333
Jun 29, 2026 4.37 5.53 4.31 5.43 5.43 379,818
Jun 26, 2026 4.12 4.45 4.08 4.37 4.37 3,867,786
Jun 25, 2026 4.30 4.60 4.00 4.11 4.11 211,336
Jun 24, 2026 4.33 4.53 4.22 4.33 4.33 131,130
Jun 23, 2026 4.51 4.73 4.33 4.35 4.35 126,440
Jun 22, 2026 4.50 4.74 4.38 4.66 4.66 164,926
Jun 18, 2026 4.19 4.64 4.06 4.47 4.47 574,967
Jun 17, 2026 4.38 4.44 4.17 4.19 4.19 196,856
Jun 16, 2026 4.39 4.53 4.30 4.37 4.37 96,404
Jun 15, 2026 4.61 4.71 4.29 4.39 4.39 132,514
Jun 12, 2026 4.69 4.75 4.40 4.51 4.51 83,000
Jun 11, 2026 4.61 4.81 4.61 4.62 4.62 107,703
Jun 10, 2026 4.73 4.92 4.63 4.67 4.67 78,764
Jun 9, 2026 4.67 4.87 4.57 4.74 4.74 96,309
Jun 8, 2026 5.01 5.18 4.56 4.63 4.63 110,694
Jun 5, 2026 4.76 4.98 4.45 4.96 4.96 114,095
Jun 4, 2026 4.73 4.88 4.62 4.78 4.78 57,428
Jun 3, 2026 4.69 4.98 4.62 4.68 4.68 108,608
Jun 2, 2026 4.78 5.04 4.50 4.75 4.75 203,572
Jun 1, 2026 4.91 5.26 4.82 4.84 4.84 94,953
May 29, 2026 4.98 5.01 4.85 4.91 4.91 58,160
May 28, 2026 5.20 5.32 5.00 5.00 5.00 92,105
May 27, 2026 5.24 5.49 5.20 5.26 5.26 90,761
May 26, 2026 5.26 5.50 5.05 5.22 5.22 175,315
May 22, 2026 5.34 5.57 5.20 5.26 5.26 84,013
May 21, 2026 5.03 5.61 4.86 5.30 5.30 225,570
May 20, 2026 4.42 5.08 4.32 5.03 5.03 414,909
May 19, 2026 4.72 4.86 4.29 4.36 4.36 303,838
May 18, 2026 5.34 5.34 4.70 4.74 4.74 122,331
May 15, 2026 5.43 5.53 5.16 5.21 5.21 90,311
May 14, 2026 5.54 5.60 5.33 5.50 5.50 63,027
May 13, 2026 5.54 5.83 5.54 5.55 5.55 351,806
May 12, 2026 5.58 5.74 5.58 5.60 5.60 80,076
May 11, 2026 5.86 6.05 5.60 5.63 5.63 66,537
May 8, 2026 6.10 6.10 5.86 5.88 5.88 74,685
May 7, 2026 6.18 6.23 6.02 6.12 6.12 71,914
May 6, 2026 6.31 6.33 6.02 6.23 6.23 87,912
May 5, 2026 6.39 6.39 5.88 6.25 6.25 115,510
May 4, 2026 6.08 6.39 6.08 6.33 6.33 120,082
May 1, 2026 6.50 6.50 6.05 6.07 6.07 108,381
Apr 30, 2026 6.51 6.59 6.20 6.47 6.47 140,228
Apr 29, 2026 6.49 6.63 6.17 6.39 6.39 88,327
Apr 28, 2026 6.49 6.50 6.24 6.44 6.44 116,525
Apr 27, 2026 6.61 6.91 6.39 6.43 6.43 168,575
Apr 24, 2026 6.70 6.83 6.09 6.58 6.58 188,072
Apr 23, 2026 7.34 7.42 6.83 6.83 6.83 97,035
Apr 22, 2026 7.11 7.58 6.86 7.35 7.35 142,853
Apr 21, 2026 6.89 7.46 6.67 6.97 6.97 232,048
Apr 20, 2026 6.68 6.95 6.49 6.89 6.89 243,448
Apr 17, 2026 6.43 6.75 6.25 6.73 6.73 265,496
Apr 16, 2026 6.18 6.52 6.03 6.29 6.29 185,300
Apr 15, 2026 6.08 6.65 5.80 6.18 6.18 294,680
Apr 14, 2026 5.67 5.94 5.67 5.87 5.87 138,346
Apr 13, 2026 5.52 5.77 5.49 5.70 5.70 120,183
Apr 10, 2026 6.03 6.08 5.48 5.51 5.51 309,537
Apr 9, 2026 5.44 6.08 5.13 6.02 6.02 363,250
Apr 8, 2026 5.29 5.48 5.16 5.42 5.42 342,930
Apr 7, 2026 5.26 5.34 5.13 5.18 5.18 157,422
Apr 6, 2026 5.25 5.43 5.02 5.23 5.23 231,754
Apr 2, 2026 5.46 5.66 5.25 5.28 5.28 188,600
Apr 1, 2026 6.12 6.16 5.59 5.60 5.60 165,091
Mar 31, 2026 5.85 6.25 5.85 6.03 6.03 167,301
Mar 30, 2026 6.03 6.35 5.94 5.97 5.97 148,851
Mar 27, 2026 6.05 6.50 5.96 6.18 6.18 167,779
Mar 26, 2026 6.01 6.31 5.79 6.14 6.14 326,112
Mar 25, 2026 6.18 6.48 6.05 6.10 6.10 175,782
Mar 24, 2026 6.42 6.52 5.73 6.04 6.04 735,313
Mar 23, 2026 7.37 8.05 6.42 6.55 6.55 681,376
Mar 20, 2026 8.00 8.17 7.52 7.54 7.54 2,259,252
Mar 19, 2026 7.79 8.38 7.71 8.07 8.07 638,356
Mar 18, 2026 7.92 8.11 7.63 7.78 7.78 512,971
Mar 17, 2026 7.74 8.25 7.74 7.85 7.85 331,878
Mar 16, 2026 7.75 8.80 7.67 7.84 7.84 377,654
Mar 13, 2026 7.60 8.03 7.55 7.83 7.83 243,610
Mar 12, 2026 7.27 7.79 7.05 7.69 7.69 262,097
Mar 11, 2026 7.65 7.86 7.26 7.30 7.30 222,334
Mar 10, 2026 7.69 8.56 7.59 7.94 7.94 356,361
Mar 9, 2026 6.02 8.15 6.00 8.00 8.00 588,635
Mar 6, 2026 5.85 6.37 5.80 6.01 6.01 86,658
Mar 5, 2026 6.70 6.70 5.02 5.94 5.94 594,456
Mar 4, 2026 6.79 7.09 6.71 6.83 6.83 106,189
Mar 3, 2026 6.80 7.19 6.70 6.86 6.86 144,074
Mar 2, 2026 6.42 6.92 6.23 6.90 6.90 206,467
Feb 27, 2026 6.15 6.67 6.15 6.60 6.60 83,828
Feb 26, 2026 6.23 6.34 6.11 6.23 6.23 30,332
Feb 25, 2026 6.22 6.50 6.15 6.23 6.23 49,165
Feb 24, 2026 6.33 6.60 5.91 6.25 6.25 113,906
Feb 23, 2026 6.21 6.65 5.87 6.32 6.32 156,295
Feb 20, 2026 6.18 6.50 6.13 6.31 6.31 75,630
Feb 19, 2026 6.29 6.58 5.66 6.34 6.34 163,466
Feb 18, 2026 6.35 6.63 6.35 6.45 6.45 82,595
Feb 17, 2026 6.29 6.69 6.09 6.45 6.45 135,521
Feb 13, 2026 6.29 6.40 6.21 6.27 6.27 67,299
Feb 12, 2026 6.22 6.35 6.00 6.29 6.29 64,363
Feb 11, 2026 6.34 6.39 5.86 6.33 6.33 116,124
Feb 10, 2026 5.65 6.47 5.61 6.31 6.31 220,637
Feb 9, 2026 4.79 5.85 4.71 5.65 5.65 308,392
Feb 6, 2026 4.29 4.92 4.13 4.80 4.80 78,067
Feb 5, 2026 4.56 4.73 4.19 4.22 4.22 105,577
Feb 4, 2026 4.85 4.88 4.50 4.67 4.67 66,507
Feb 3, 2026 4.69 4.99 4.50 4.93 4.93 133,854
Feb 2, 2026 4.12 4.91 4.12 4.68 4.68 191,083
Jan 30, 2026 4.24 4.35 3.98 4.06 4.06 32,420
Jan 29, 2026 4.19 4.29 4.05 4.20 4.20 54,348
Jan 28, 2026 4.34 4.49 4.16 4.17 4.17 55,083
Jan 27, 2026 4.04 4.46 3.95 4.35 4.35 84,413
Jan 26, 2026 3.94 4.24 3.90 4.07 4.07 65,902
Jan 23, 2026 3.96 4.14 3.88 3.97 3.97 71,337
Jan 22, 2026 3.81 4.10 3.75 3.90 3.90 157,796
Jan 21, 2026 4.36 4.65 4.11 4.19 4.19 67,114
Jan 20, 2026 4.37 4.55 4.25 4.37 4.37 51,236
Jan 16, 2026 4.36 4.51 4.21 4.45 4.45 34,950
Jan 15, 2026 4.34 4.54 4.14 4.33 4.33 92,284
Jan 14, 2026 4.27 4.39 4.10 4.31 4.31 50,523
Jan 13, 2026 4.31 4.31 4.08 4.27 4.27 16,927
Jan 12, 2026 4.45 4.51 3.96 4.32 4.32 69,988
Jan 9, 2026 4.75 4.75 4.38 4.45 4.45 52,296
Jan 8, 2026 4.77 4.77 4.53 4.70 4.70 63,141
Jan 7, 2026 4.25 4.86 4.25 4.71 4.71 189,367
Jan 6, 2026 4.07 4.44 4.05 4.32 4.32 138,640
Jan 5, 2026 3.96 4.20 3.90 4.15 4.15 65,492
Jan 2, 2026 4.01 4.20 3.82 3.92 3.92 37,860
Dec 31, 2025 4.09 4.21 3.94 4.02 4.02 69,150
Dec 30, 2025 3.91 4.24 3.90 4.06 4.06 81,184
Dec 29, 2025 4.13 4.18 4.07 4.09 4.09 38,951
Dec 26, 2025 3.95 4.20 3.90 4.19 4.19 54,632
Dec 24, 2025 3.96 4.03 3.96 3.97 3.97 8,391
Dec 23, 2025 3.91 4.07 3.88 4.06 4.06 30,757
Dec 22, 2025 4.00 4.06 3.88 3.98 3.98 19,403
Dec 19, 2025 3.85 4.07 3.82 4.04 4.04 19,465
Dec 18, 2025 3.80 4.00 3.77 3.87 3.87 16,417
Dec 17, 2025 4.11 4.16 3.77 3.80 3.80 44,614
Dec 16, 2025 4.00 4.25 3.83 4.17 4.17 48,299
Dec 15, 2025 3.76 4.15 3.70 4.04 4.04 45,103
Dec 12, 2025 4.06 4.08 3.86 3.88 3.88 37,317
Dec 11, 2025 3.79 4.17 3.64 4.08 4.08 57,761
Dec 10, 2025 3.90 3.99 3.75 3.91 3.91 45,171
Dec 9, 2025 3.86 3.93 3.51 3.90 3.90 42,312
Dec 8, 2025 3.83 3.92 3.76 3.87 3.87 22,332
Dec 5, 2025 3.73 3.85 3.54 3.84 3.84 24,227
Dec 4, 2025 3.27 3.79 3.27 3.74 3.74 35,993
Dec 3, 2025 3.26 3.43 3.25 3.33 3.33 67,339
Dec 2, 2025 3.77 3.79 3.25 3.25 3.25 97,307
Dec 1, 2025 4.12 4.17 3.71 3.80 3.80 82,644
Nov 28, 2025 3.80 4.21 3.80 4.18 4.18 36,630
Nov 26, 2025 3.79 3.94 3.76 3.78 3.78 26,447
Nov 25, 2025 3.77 3.96 3.76 3.77 3.77 29,521
Nov 24, 2025 3.95 4.10 3.78 3.78 3.78 59,396
Nov 21, 2025 4.31 4.31 3.93 3.94 3.94 42,715
Nov 20, 2025 4.30 4.38 4.11 4.34 4.34 72,738
Nov 19, 2025 4.20 4.42 4.14 4.30 4.30 40,991
Nov 18, 2025 4.30 4.38 4.07 4.30 4.30 177,908
Nov 17, 2025 4.17 4.60 3.90 4.36 4.36 319,181
Nov 14, 2025 3.75 4.23 3.75 4.11 4.11 90,035
Nov 13, 2025 3.88 3.98 3.78 3.85 3.85 79,159
Nov 12, 2025 3.91 4.20 3.90 4.00 4.00 70,100
Nov 11, 2025 3.85 4.05 3.76 3.97 3.97 73,631
Nov 10, 2025 3.78 3.86 3.63 3.81 3.81 52,776
Nov 7, 2025 3.68 3.91 3.52 3.71 3.71 124,111
Nov 6, 2025 3.80 3.81 3.53 3.64 3.64 111,838
Nov 5, 2025 3.50 4.00 3.50 3.82 3.82 143,924
Nov 4, 2025 3.78 3.83 3.60 3.67 3.67 77,194
Nov 3, 2025 4.15 4.35 3.77 3.82 3.82 134,381
Oct 31, 2025 4.01 4.30 4.01 4.20 4.20 99,375
Oct 30, 2025 4.14 4.38 4.00 4.04 4.04 194,010
Oct 29, 2025 4.72 4.80 4.13 4.23 4.23 414,729
Oct 28, 2025 4.46 4.80 4.45 4.60 4.60 430,415
Oct 27, 2025 4.64 4.80 4.25 4.53 4.53 396,121
Oct 24, 2025 4.53 5.10 4.50 4.70 4.70 881,624
Oct 23, 2025 5.18 5.61 4.82 4.87 4.87 727,504
Oct 22, 2025 5.25 5.78 4.41 5.38 5.38 3,806,499
Oct 21, 2025 6.74 12.46 5.98 6.41 6.41 166,732,452
Oct 20, 2025 2.48 2.71 2.48 2.66 2.66 131,814
Oct 17, 2025 2.41 2.64 2.40 2.49 2.49 48,421
Oct 16, 2025 2.51 2.58 2.44 2.53 2.53 66,132
Oct 15, 2025 2.47 2.72 2.39 2.51 2.51 93,447
Oct 14, 2025 2.41 2.60 2.41 2.54 2.54 73,226
Oct 13, 2025 2.38 2.55 2.24 2.53 2.53 83,655
Oct 10, 2025 2.42 2.60 2.31 2.35 2.35 134,460
Oct 9, 2025 2.63 2.76 2.56 2.57 2.57 310,489
Oct 8, 2025 2.63 3.29 2.49 2.83 2.83 8,936,144
Oct 7, 2025 2.12 2.18 2.12 2.18 2.18 3,876,739
Oct 6, 2025 2.08 2.14 2.08 2.14 2.14 6,298
Oct 3, 2025 2.08 2.14 2.08 2.10 2.10 7,128
Oct 2, 2025 2.12 2.15 2.08 2.11 2.11 5,521
Oct 1, 2025 2.06 2.14 2.06 2.10 2.10 2,656
Sep 30, 2025 2.20 2.22 2.10 2.10 2.10 5,016
Sep 29, 2025 2.12 2.20 2.10 2.10 2.10 2,654
Sep 26, 2025 2.14 2.14 2.08 2.12 2.12 8,740
Sep 25, 2025 2.22 2.27 2.12 2.17 2.17 17,012
Sep 24, 2025 2.09 2.43 2.08 2.19 2.19 32,194
Sep 23, 2025 2.04 2.15 2.04 2.09 2.09 15,397

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Minerva Neurosciences, Inc Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at NERV, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation